1 year return (CAGR)
126.92%
Candel Therapeutics Inc Exchange (NASDAQ, USD)
CADL
11.21
+0.36 (+3.32%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
110.03%
5 year return (CAGR)
6.17%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
857.77M
Price/Sales
-
Ent value
738.23M
Price/Book
6.80
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-5.30%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 11.85 |
| Daily high | 11.90 |
| Daily low | 11.13 |
| Daily Volume | 1.09M |
| All-time high | 14.00 |
| 1y analyst estimate | 21.00 |
| Beta | -0.50 |
| EPS (TTM) | -1.19 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CADL | S&P500 | |
| Current price drop from All-time high | -19.93% | -0.56% |
| Highest price drop | -94.33% | -56.47% |
| Date of highest drop | 3 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -60.55% | -10.68% |
| Avg time to new high | 118 days | 12 days |
| Max time to new high | 641 days | 1805 days |
News
